AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
JP¥5,036.00
+0 (+0%)
At Close: May 21, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About CHUGAI PHARMACEUTICAL CO.,LTD.

CHUGAI PHARMACEUTICAL Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and ne... 4519.T Profile

Golden Star

Ticker Date Change Price
TTWO May 16 3.30% $146.08
LYV May 16 3.16% $96.38
BDX May 16 0.216% $236.62
CNI May 16 1.30% $126.57
INBX May 15 0.262% $34.37
PAGS May 15 1.88% $12.74
LNG May 14 1.51% $157.42
CME May 14 0.223% $210.80
VGIT May 14 0.0692% $57.83
VCLT May 14 0.621% $75.73
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT